Wu Bu-yun, Liu Kang, Ge Yi-fei, Xu Xue-qiang, Xing Chang-ying, Mao Hui-juan. Anticoagulation of nafamostat mesylate for double filtration plasmapheresis: a report of four cases with a literature review[J]. Journal of Clinical Nephrology, 2023, 23(6): 522-525. DOI: 10.3969/j.issn.1671-2390.2023.06.015
|
Citation:
|
Wu Bu-yun, Liu Kang, Ge Yi-fei, Xu Xue-qiang, Xing Chang-ying, Mao Hui-juan. Anticoagulation of nafamostat mesylate for double filtration plasmapheresis: a report of four cases with a literature review[J]. Journal of Clinical Nephrology, 2023, 23(6): 522-525. DOI: 10.3969/j.issn.1671-2390.2023.06.015
|
Wu Bu-yun, Liu Kang, Ge Yi-fei, Xu Xue-qiang, Xing Chang-ying, Mao Hui-juan. Anticoagulation of nafamostat mesylate for double filtration plasmapheresis: a report of four cases with a literature review[J]. Journal of Clinical Nephrology, 2023, 23(6): 522-525. DOI: 10.3969/j.issn.1671-2390.2023.06.015
|
Citation:
|
Wu Bu-yun, Liu Kang, Ge Yi-fei, Xu Xue-qiang, Xing Chang-ying, Mao Hui-juan. Anticoagulation of nafamostat mesylate for double filtration plasmapheresis: a report of four cases with a literature review[J]. Journal of Clinical Nephrology, 2023, 23(6): 522-525. DOI: 10.3969/j.issn.1671-2390.2023.06.015
|
.png)
DownLoad: